Lataa...
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
Modified citrus pectin (MCP) is a carbohydrate enriched complex, which has been implicated in cancer treatment and prevention. However, the effects of MCP on urinary bladder cancer (UBC) are unknown. In this study, MCP was first tested in T24 and J82 human UBC cells and showed the inhibition of cell...
Tallennettuna:
| Julkaisussa: | Acta Pharmacol Sin |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6289393/ https://ncbi.nlm.nih.gov/pubmed/29769742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-018-0004-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|